Ranibizumab for subfoveal choroidal neovascularisation associated with Stargardt disease.

Battaglia Parodi, M; Munk, Marion; Iacono, P; Bandello, F (2015). Ranibizumab for subfoveal choroidal neovascularisation associated with Stargardt disease. British journal of ophthalmology, 99(9), pp. 1268-1270. BMJ Publishing Group 10.1136/bjophthalmol-2014-305783

[img] Text
1268.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (459kB) | Request a copy

INTRODUCTION: To describe the clinical outcomes of intravitreal ranibizumab treatment for subfoveal choroidal neovascularisation (CNV) associated with Stargardt disease. METHODS: Prospective, interventional, case series. All patients underwent intravitreal ranibizumab injections following a pro re nata regimen with monthly examination, over a 24-month follow-up. RESULTS: Three eyes were included in the study. Best corrected visual acuity changed from 0.47±0.06 (mean±SD) at baseline to 0.90±0.17 LogMAR at the end of the 24-month follow-up. Overall, a mean number of 11 ranibizumab injections were administered in 24 months. Significant atrophic growth was detected in all cases, with the mean atrophy area increasing from 2.34±2.60 mm(2) (mean±SD) at baseline to 4.23±3.31 mm(2) at the end of the follow-up. CONCLUSIONS: Ranibizumab treatment can stop the CNV progression, but cannot ensure a significant visual improvement. Macular atrophy tends to significantly enlarge under ranibizumab treatment over the follow-up. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Munk, Marion

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0007-1161

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Marion Munk

Date Deposited:

12 Apr 2016 10:12

Last Modified:

12 Apr 2016 10:12

Publisher DOI:

10.1136/bjophthalmol-2014-305783

PubMed ID:

25740804

BORIS DOI:

10.7892/boris.80109

URI:

https://boris.unibe.ch/id/eprint/80109

Actions (login required)

Edit item Edit item
Provide Feedback